Document is current
Any future updates will be listed below
-
Authors
DeMichele, Angela https://orcid.org/0000-0003-1297-4251
Clark, Amy S. https://orcid.org/0000-0002-3685-6535
Shea, Emily
Bayne, Lauren J.
Sterner, Christopher J.
Rohn, Killian
Dwyer, Samantha
Pan, Tien-chi
Nivar, Isoris
Chen, Yan
Wileyto, Paul
Berry, Lindsay R.
Deluca, Shannon
Savage, Jessica
Makhlin, Igor https://orcid.org/0000-0001-7374-7330
Pant, Dhruv K.
Martin, Heather
Egunsola, Adetutu
Mears, Nathan
Goodspeed, Brooke L.
Chislock, Elizabeth M.
Graves, Jewell
Wang, Jianping
Shih, Natalie
Belka, George K.
Berry, Don
Nayak, Anupma
Feldman, Michael
Chodosh, Lewis A. https://orcid.org/0000-0003-1027-8674
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 29 June 2024
Accepted: 1 July 2025
First Online: 2 September 2025
Competing interests
: A.D. has received institutional research funding from Novartis, Genentech, Pfizer and NeoGenomics. L.A.C. has received institutional research funding from Novartis, AstraZeneca and Merck Research Laboratories, and has served as an expert consultant to Teva Pharmaceuticals, Eisai, Sanofi, Takeda Pharmaceuticals, Eli Lilly, Whittaker, Clark and Daniels, Wyeth, Imerys, Becton Dickinson, Sterigenics and the U.S. Department of Justice in litigation. The other authors declare no competing interests.
